| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
4e-16 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-13 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.3 |
1e-10 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
4e-09 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-09 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
7e-09 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
7e-09 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-08 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.24 |
2e-07 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-07 |